Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study (Q35638054)

9 August 2017

title

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study (English)

1 reference

9 August 2017

1 reference

D Khanna

1

1 reference

9 August 2017

D E Furst

2

1 reference

9 August 2017

R D Hays

3

1 reference

9 August 2017

G S Park

4

1 reference

9 August 2017

W K Wong

5

1 reference

9 August 2017

J R Seibold

6

1 reference

9 August 2017

M D Mayes

7

1 reference

9 August 2017

B White

8

1 reference

9 August 2017

F F Wigley

9

1 reference

9 August 2017

M Weisman

10

1 reference

9 August 2017

W Barr

11

1 reference

9 August 2017

L Moreland

12

1 reference

9 August 2017

T A Medsger

13

1 reference

9 August 2017

V D Steen

14

1 reference

9 August 2017

R W Martin

15

1 reference

9 August 2017

D Collier

16

1 reference

9 August 2017

A Weinstein

17

1 reference

9 August 2017

E V Lally

18

1 reference

9 August 2017

J Varga

19

1 reference

9 August 2017

S R Weiner

20

1 reference

9 August 2017

B Andrews

21

1 reference

9 August 2017

M Abeles

22

1 reference

9 August 2017

P J Clements

23

1 reference

9 August 2017

language of work or name

English

0 references

publication date

15 March 2006

1 reference

Annals of the Rheumatic Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

65

1 reference

9 August 2017

issue

10

1 reference

9 August 2017

page(s)

1325-1329

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

9 August 2017

1 reference

Approaches and recommendations for estimating minimally important differences for health-related quality of life measures

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Surveying physicians to determine the minimal important difference: implications for sample-size calculation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Measurement of health status. Ascertaining the minimal clinically important difference

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Defining clinically meaningful change in health-related quality of life.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798331

A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis

25 September 2018

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Comparisons of Five Health Status Instruments for Orthopedic Evaluation

1 reference

12 December 2020

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

12 December 2020

Responsiveness to change: an aspect of validity, not a separate dimension

1 reference

12 December 2020

Measurement of skin involvement in scleroderma

1 reference

12 December 2020

Estimating clinically significant differences in quality of life outcomes

1 reference

12 December 2020

Systemic sclerosis (scleroderma) and related disorders: clinical aspects

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2005.050187

1 reference

9 August 2017

1 reference

9 August 2017

1 reference